We are aware of fraudulent emails, texts, and job postings claiming to be from Immunovant. These messages often attempt to deceive individuals into believing they have been selected for an interview or job that is not officially posted by our company. Please be aware that: ? All legitimate job applications should be submitted through our careers site at?immunovant.com/join-us/ ? Our HR team does not conduct interviews through Telegram, Google Hangouts, or Microsoft Teams. The majority of our interviews are conducted via Zoom.?? ?We never ask for bank information or money for IT equipment as part of our recruitment process. To protect yourself: ? Always verify job postings on our official careers page.?? ? Never share personal information unless you’re confident the request is legitimate.?? ? Contact us directly at?[email protected]?if you receive suspicious communication or have concerns. Thank you for helping us maintain a safe and secure job application process.??
关于我们
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com. For U.S. residents only.
- 网站
-
https://www.immunovant.com/join-us/values-culture
Immunovant的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- New York
- 类型
- 上市公司
- 创立
- 2018
- 领域
- Autoimmune disease
地点
Immunovant员工
-
Richard (Reb) Buckley JD, MBA
Director of Site Technology Solutions @ Immunovant | Clinical Innovation Leader | Industry Collaborator | Industry Speaker/Panelist | Change…
-
Diane Harper, PhD, JD, RAC
-
Anirban Mukherjee
Procurement and Supplier Management Strategist | Progressive Experience with Fortune 200 Companies | Hands On Biotech Leadership | Multi-Industry…
-
Carey Acquafresca
动态
-
Today, we reported results from our Phase 3 study of batoclimab in myasthenia gravis and initial results from our Phase 2b study in chronic inflammatory demyelinating polyneuropathy. Read more here: https://lnkd.in/eBvQc2ya #autoimmune #AutoimmuneDisease #PatientFirst #InvisibleDisability #MyastheniaGravis #ChronicInflammatoryDemyelinatingPolyneuropathy #CIDP #RareAutoimmuneDisease
-
-
Shannon and Colleen (sisters) have been attending events such as Myasthenia Gravis Foundation of America, Inc.'s #MGwalk since 2008. In this video, they share their ‘why’ for doing so. At Immunovant, we understand the complex and variable needs of people living with #MyastheniaGravis. Learn more about our clinical research programs in MG at https://lnkd.in/etriCUUd #MGstrong #autoimmune #AutoimmuneDisease #PatientFirst #InvisibleDisability #advocacy
-
In honor of #AutoimmuneAwarenessMonth the Autoimmune Association created a “Proclamation Toolkit” to help raise awareness of #AutoimmuneDisease. Learn more about getting involved here: https://lnkd.in/gM7-N-Bw Our company understands that people with autoimmune diseases have complex and variable needs. Learn more about our clinical research programs in MG, Graves’ disease, TED, CIDP and RA, here: https://lnkd.in/etriCUUd #autoimmune #AutoimmuneDisease #PatientFirst #InvisibleDisability #MyastheniaGravis #GravesDisease #TED #ThyroidEyeDisease #ChronicInflammatoryDemyelinatingPolyneuropathy #CIDP #RheumatoidArthritis #RareAutoimmuneDisease
-
-
Thank you to the EveryLife Foundation for Rare Diseases for providing the venue for #RareDiseaseWeek at the Capitol! This event convenes advocates from multiple rare disease communities. Cheryl Hostinak, Director of Patient Advocacy at Immunovant (pictured right) had a chance to connect with advocate, Jenifer Waldrop from the Rare Disease Diversity Coalition, who shared her thoughts on the value of attending this event. Learn more about Rare Disease Week on Capitol Hill: https://lnkd.in/dNrRZP2 #RareDiseaseDay #RareDC2025 #RDDC #RareDisease #autoimmune #AutoimmuneDisease #PatientFirst #InvisibleDisability #MyastheniaGravis #ChronicInflammatoryDemyelinatingPolyneuropathy #CIDP #RareAutoimmuneDisease
-
-
Living with an autoimmune condition can feel isolating, especially without a care partner. In this video, Andre shares the primary role he serves for his wife, Cynthia, who lives with Graves’ disease and thyroid eye disease (TED). At Immunovant we’re advancing #ClinicalTrials with potential treatments for people living with #TED and #GravesDisease. To learn more visit: https://lnkd.in/et59gnua #autoimmune #AutoimmuneDisease #PatientFirst #InvisibleDisability TED Community Organization
-
"Growing up in a small town where few people looked like us, my parents taught me to show up confidently, own who I am, and never shy away. They encouraged my dreams, supported me through failures, and showed me that setbacks are just?stepping-stones. Their wisdom now guides me as I build a legacy with my own family, passing down the same values of resilience and purpose." - Torchia Dendy, Associate Director, HR Business Partner at Immunovant Thank you, Torchia, for sharing the ongoing influence your parents have on your life in honor of #BlackHistoryMonth! To learn more about Immunovant’s values and culture, visit: https://lnkd.in/eQQDXAJy #autoimmune #AutoimmuneDisease #PatientFirst #RareDisease #InvisibleDisability
-
-
"We are energized by the progress of our IMVT-1402 development plans, with six INDs now cleared and all clinical studies to be conducted using standard YpsoMate? autoinjector technology and our planned commercial formulation," said Pete Salzmann, M.D., chief executive officer of Immunovant. Read more about our financial results for our fiscal quarter ended December 31, 2024 by visiting: https://lnkd.in/gAk7Z5fD #PressRelease #batoclimab #GravesDisease #FcRn #RheumatoidArthritis #CIDP #ThyroidEyeDisease #MyastheniaGravis #AntithyroidDrugs #thyroid #hyperthyroidism #InvisibleDisability #AutoImmuneDisease #autoimmune #PatientFirst #healthcare #IMVT #IMVT1402
-
-
As we recognize #ThyroidAwarenessMonth, did you know that #ThyroidEyeDisease and #GravesDisease are autoimmune diseases? In people with TED, harmful IgG autoantibodies target the muscle, fat and tissue around the eye, which can result in symptoms that can have a significant impact on an individual's emotional well-being and quality of life. These same autoantibodies also affect the thyroid in people with Graves’ disease. Learn more about TED symptoms and Immunovant’s patient-focused approach to advance treatments here: https://lnkd.in/e7HwrJUV #RareDisease #RareVoice #InvisibleDisability #AutoImmuneDisease #autoimmune #PatientFirst #healthcare
-
Spotlighting #GravesDisease in honor of #ThyroidAwarenessMonth. Graves’ disease is a common autoimmune disease in which the body overproduces thyroid hormones, causing #hyperthyroidism. Treatment approaches for Graves’ disease have remained largely unchanged for approximately 70 years. Current treatments target the thyroid to reduce the level of thyroid hormones, rather than the underlying disease driver: harmful IgG autoantibodies. Learn more about Graves’ disease and our work here: https://lnkd.in/e7HwrJUV #InvisibleDisability #AutoimmuneDisease #autoimmune #thyroid #PatientFirst #healthcare